Back

Association between heart rate thresholds for cardiovascular risk defined by new ESC/ESH Guidelines and neuroadrenergic markers.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Clinical risk factors, prevalence and prognosis Epidemiology ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Gino Seravalle

San Luca Hospital of Milan, Milan (Italy)

13 More presentations in this session

Presentation thumbnail
Identification of patients at extremely-high cardiovascular risk within a very-high risk population from the TERCET Registry.
Associate Professor K. Dyrbus (Zabrze, PL)
Abstract Slides
Presentation thumbnail
Risk Or Benefit IN Screening for CArdiovascular disease (ROBINSCA): results from screening for a high cardiovascular disease risk by using a risk prediction model or coronary artery calcium scoring
Professor H. de Koning (Rotterdam, NL)
Abstract
Presentation thumbnail
Cystatin C based eGFR estimation compared to crea-based estimation equation for assessing risk of cardiovascular and total mortality in population-based studies and patients with manifest CVD
Professor W. Koenig (Munich, DE)
Abstract
Presentation thumbnail
Influence of TCF21 rs12190287 in the coronary artery disease risk prediction. An association study in a Portuguese population.
Doctor J. Sousa (Funchal, PT)
Abstract Slides
Presentation thumbnail
Definition of extremely high cardiovascular risk in patients after acute myocardial infarction - Data from the TERCET Registry.
Associate Professor K. Dyrbus (Zabrze, PL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Clinical risk factors, prevalence and prognosis

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Making personalised prevention everyone's business
thumbnail
Congress Presentation
Saving hearts, extending lives: the impact of risk prevention on lifetime estimates in Germany
thumbnail
Congress Presentation
Cardiovascular prevention in older adults

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources